Egis Gyogyszergyar

Egis Gyogyszergyar Rt.

Other

Basf Aktiengesellschaft

Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag

Egis Gyogyszergyar Zrt.

Gis Gyogyszergyar Rt.

Egis Gyoyszergyar Rt

Egis Gyogyszergyat

Istvan Gacsalyi

Istvan Gyertyan

Lujza E Petocz

Marton Fekete

Gabor Gigler

Gyula Simig

Gabor Blasko

Zoltan Budai

Jozsef Reiter

Jozsef Barkoczy

Eniko Szirt Nee Kiszelly

Andras Egyed

Maria Szecsey Nee Hegedus

Tibor Mezei

Frigyes Gorgenyi

Klara Reiter Nee Esses

Katalin Szemeredi

Eva Schmidt

Laszlo Pongo

Andras Bilkei-Gorzo

Jozsef Knoll

Attila Mandi

Gabor Nemeth

Daniel Bozsing

Berta Knoll

Karoly Tihanyi

Endre Rivo

Judit Bajnogel

Gabriella Zsilla

Imre Moravcsik

Ferenc Andrasi

Tamas Hamori

Pal Berzsenyi

Balazs Volk

Aranka Lay Nee Konya

Imre Klebovich

Gabor Zolyomi

Peter Tompe

Edit Berenyi Nee Poldermann

Pal Vago

Gyula Lukacs

Istvan Ling

Katalin Pallagi

Laszlo Rozsa

Eszter Szentkuti

Andras Dancso

Eva Furdyga

Anna Bakonyi

Katalin Horvath

Klara Kazo Nee Daroczi

Katalin Budai Nee Simonyi

Hajnalka Kompagne

Szabolcs Kertesz

Enik Szirt Nee Kiszelly

Edit Horvath

Janos Petho

Ferenc Antoni

Gyorgyne Mate

Imre Doman

Aniko Miklos Nee Kovacs

Frigyes Gogenyi

Josef Reiter

Cecilia Salamon Haskane

Klara Daroczi Kazone

Peter Korosi

Aniko Kovacs

Hilda Botka

Gyula Balogh, Deceased

Erzsebet Kovacs Nee Kaszab

Kalara Reiter Nee Esses

Josef Barkoczy

Luiza Petocz

Klara Reiter Nee Eszes

Klara Reiter Nee Esess

Ludmilla Rohacas Nee Zamkovaja

Lászlo Gabor Harsing

Agnes Kenez

Ferenc Bertha

Balazs Mihalik

Agnes Angyalne Pataki

Gabor Laszlo Kapus

Adrienn Palvolgyi

Lax Gyorgyi Kovanyine

Marta Agoston

Gyoergy Levay

Gabor Szenas

Ne Simonyi Budai

Ivan Jakoczi

Ildiko Ratz Nee Simonek

Erzsebet Kaufmanne Bojti

Andras Bilkei Gorzo

Miklos Abermann

Katalin Baloghne Nemes

Gyula Grezal

Istvan Gertyan

Edit Berenyi Ne Poldermann

Compounds of formula (I) having a selective dual action on the central GABAergic system, and a process for their preparation and to pharmaceutical compositions containing them.

Dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them

The invention relates the use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazole-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or pharmaceutically acceptable salts thereof for the preparation of medicaments suitable for the improvement of cognitive function or obtaining neuroprotective effect. The medicaments containing 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazol-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or therapeutically acceptable salt thereof can be used for the treatment or prevention of neuronal death, mental decline, sclerosis multiplex, Creuzfeld-Jacobs disease, Huntington-syndrome, amyotrophic lateral sclerosis, Parkinson-disease, memory disturbance, loss of memory, amnesia, stroke or for the improvement of memory function or learning ability.

Medicament for the enhancement of cognitive function and neuroprotection

Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions

1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives as anxiolytic agents

This invention relates to new 1-�2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said benzodiazepine derivatives for the treatment of diseases and for the preparation of pharmaceutical compositions suitable for the treatment of diseases. The compounds according to the invention correspond to the general formula (I), ##STR1## wherein the variables are herein below defined, and the compounds possess central nervous activities.

1-�2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives

The invention relates to anxiolytic pharmaceutical compositions comprising as active ingredient 1-sytrylisoquinoline derivatives of general formula (I), wherein

Heterocyclic compounds, pharmaceutical compositions comprising them and

The invention refers to a pharmaceutical composition, a process for the preparation thereof and a novel medical use of bicycloheptane derivatives. The pharmaceutical compositions of the invention comprise a bicycloheptane derivative of the formula I ##STR1## wherein said derivative is as defined in the specification herein. The pharmaceutical compositions of the invention are suitable for the treatment of diseases and disorders that are connected with the influence on the cholecystokinin system, especially for preventing the spastic contraction of the gallbladder.

Pharmaceutical compositions containing bicycloheptane ether amines and a

Novel basic ether of general formula (I), ##STR1## wherein R.sup.1 and R.sup.2 are independently hydrogen, halogen or C.sub.1-4 alkoxy, or together they represent a 3,4-methylenedioxy group,

Basic ethers and process for the preparation thereof

The invention relates to novel, pharmaceutically active benz[e]indene derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, further to the use of the said benz[e]indene derivatives in the treatment of certain diseases and in the preparation of pharmaceutical compositions suitable for the treatment of said diseases. The new benz[e]indene derivatives according to the invention correspond to the general formula ##STR1## wherein A represents a group of the formula alk-NR.sup.1 R.sup.2, wherein alk represents a C.sub.2-7 alkylene group optionally carrying a hydroxy substituent,

Benz[e]indene derivatives

The invention relates to novel triazolyl thioamides of the general formula (I), ##STR1## wherein Q represents hydrogen or a heterocyclic group optionally bearing one or more C.sub.1-4 alkyl substituent(s), or a group of the formula SR.sup.1, wherein

Triazolyl thioamide derivates

This invention relates to novel triazolyl hydrazide derivatives and a process for the preparation thereof. The new triazolyl hydrazide derivatives of the general formula (I). ##STR1## wherein Q represents hydrogen or a heterocyclic group optionally substituted by a C.sub.1-4 alkyl group; or a group of general formula SR.sup.1, wherein

Triazolyl hydrazide derivatives

This invention relates to novel triazolo derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said triazolo derivatives for the treatment of diseases and also for the preparation of pharmaceutical compositions suitable for the treatment of the said diseases. The new triazolo derivatives of the general formulae (Ia) and (Ib), ##STR1## wherein Q represents hydrogen or a heterocyclic group optionally bearing one or more C.sub.1-4 alkyl substituent(s); or a group of the formula SR.sup.1, wherein

Triazolo derivatives and process for their preparation

The invention relates to new dihydropyrimidothiazine derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same and new intermediates useful in the preparation of the said dihydropyrimidothiazine derivatives.

Dihydropyrimidothiazine derivatives

This invention relates to novel triazolopyrimidine derivatives of formulae (Ia) and (Ib), ##STR1## wherein Q represents hydrogen, a heterocyclic group optionally substituted by a C.sub.1-4 alkyl group and containing one or more oxygen and/or nitrogen atoms or a group of formula

Novel triazolo-pyrimidine derivatives

Growing community of inventors

Budapest, Hungary

Istvan Gacsalyi